WNK2 and melanoma: One of the main reasons for the high aggressiveness of melanoma is the occurrence of a mutated form of serine-threonine kinase BRAF, a component of the mitogen-activated protein kinase (MAPK) signaling pathway, which is detected in about 50% of patients suffering from cutaneous melanoma [5].